MKI67 and breast cancer: The clinical categorization of breast cancer is based on the expression status of specific receptors, including the estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), and the Ki-67 proliferation marker protein [13,17,18].